UnitedHealth Group Incorporated (NYSE:UNH) is Sawgrass Asset Management LLC's 10th Largest Position

Sawgrass Asset Management LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 18.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,012 shares of the healthcare conglomerate's stock after selling 7,273 shares during the quarter. UnitedHealth Group accounts for approximately 1.9% of Sawgrass Asset Management LLC's portfolio, making the stock its 10th largest holding. Sawgrass Asset Management LLC's holdings in UnitedHealth Group were worth $18,717,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of UNH. Tealwood Asset Management Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $2,905,000. Asset Planning Services Inc. LA ADV raised its position in shares of UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate's stock valued at $7,288,000 after buying an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC grew its stake in shares of UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate's stock worth $14,603,000 after buying an additional 3,006 shares during the last quarter. Americana Partners LLC grew its stake in shares of UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate's stock worth $11,914,000 after purchasing an additional 1,984 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. raised its holdings in shares of UnitedHealth Group by 14.8% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate's stock worth $5,072,000 after acquiring an additional 1,283 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UNH traded down $0.92 on Friday, hitting $592.23. 3,423,919 shares of the stock were exchanged, compared to its average volume of 3,119,612. The business has a 50-day moving average of $582.84 and a two-hundred day moving average of $549.52. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The firm has a market capitalization of $545.02 billion, a price-to-earnings ratio of 38.58, a PEG ratio of 1.74 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business's revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.56 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group's payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of analyst reports. Barclays decreased their target price on shares of UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating on the stock in a research report on Tuesday, October 22nd. UBS Group dropped their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a research note on Wednesday, October 16th. KeyCorp began coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They issued an "overweight" rating and a $675.00 price objective for the company. HSBC downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, October 17th. Finally, Royal Bank of Canada decreased their target price on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research report on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.